- Home
- LSEA vs TSVT Comparison
LSEA vs TSVT Comparison
Compare LSEA & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSEA
- TSVT
- Stock Information
- Founded
- LSEA 2013
- TSVT 2021
- Country
- LSEA United States
- TSVT United States
- Employees
- LSEA N/A
- TSVT N/A
- Industry
- LSEA Homebuilding
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- LSEA Consumer Discretionary
- TSVT Health Care
- Exchange
- LSEA Nasdaq
- TSVT Nasdaq
- Market Cap
- LSEA 300.4M
- TSVT 258.9M
- IPO Year
- LSEA N/A
- TSVT N/A
- Fundamental
- Price
- LSEA $5.77
- TSVT $4.96
- Analyst Decision
- LSEA Buy
- TSVT Buy
- Analyst Count
- LSEA 4
- TSVT 5
- Target Price
- LSEA $13.75
- TSVT $7.60
- AVG Volume (30 Days)
- LSEA 356.8K
- TSVT 2.6M
- Earning Date
- LSEA 04-30-2025
- TSVT 05-07-2025
- Dividend Yield
- LSEA N/A
- TSVT N/A
- EPS Growth
- LSEA N/A
- TSVT N/A
- EPS
- LSEA 0.47
- TSVT N/A
- Revenue
- LSEA $1,550,337,000.00
- TSVT $37,862,000.00
- Revenue This Year
- LSEA $4.36
- TSVT $76.36
- Revenue Next Year
- LSEA $4.94
- TSVT $14.74
- P/E Ratio
- LSEA $12.28
- TSVT N/A
- Revenue Growth
- LSEA 28.13
- TSVT N/A
- 52 Week Low
- LSEA $5.73
- TSVT $2.29
- 52 Week High
- LSEA $14.04
- TSVT $5.90
- Technical
- Relative Strength Index (RSI)
- LSEA 31.42
- TSVT 80.15
- Support Level
- LSEA $6.16
- TSVT $2.55
- Resistance Level
- LSEA $6.54
- TSVT $4.97
- Average True Range (ATR)
- LSEA 0.36
- TSVT 0.01
- MACD
- LSEA -0.08
- TSVT -0.06
- Stochastic Oscillator
- LSEA 2.18
- TSVT 50.00
About LSEA Landsea Homes Corporation
Landsea Homes Corp is a homebuilding company. It designs and builds homes and sustainable master-planned communities in some of the nation's desirable markets. The company's segments include Arizona, California, Florida, Metro New York, and Texas. It derives a majority of revenue from home sales in Florida.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.